Otezla

Apremilast

7.0 High risk

Otezla & Psoriasis

11.9%

of users reported Psoriasis

66.4%

also reported Severe reaction

64.4%

are women

Most common medical consequences

Severe reaction
66.4%
Hospitalization
29.7%
Disability
3.1%
Life-threatening condition
0.6%
Death
<0.1%
Medical Intervention
<0.1%

Have you experienced any negative side effects from this medication?

Otezla: general information

Most common side effects (664)

Most commonly affected ages

10 - 19 years
0.7%
20 - 29 years
4.3%
30 - 39 years
9.7%
40 - 49 years
17.8%
50 - 59 years
29.2%
60 - 69 years
25.1%
70 - 79 years
10.8%
80 - 89 years
2.3%
90 - 99 years
0.2%
On this page
Otezla & Psoriasis
Otezla: general information